First international workshop of the ATM and cancer risk group (4-5 December 2019)

This report summarizes the meeting sessions content that covered the latest results in family-based and population-based studies, the importance of accurate variant classification, the effect of radiation exposures forATM variant carriers, and the characteristics of ATM-deficient tumors. The report concludes thatATM variant carriers outside of the context of Ataxia-Telangiectasia may benefit from effective cancer risk management and therapeutic strategies and that efforts to set up large-scale studies in the international framework to achieve this goal are necessary.
Source: Familial Cancer - Category: Cancer & Oncology Source Type: research